← Back to headlines
Eli Lilly and Sanofi-Backed Scribe Surges in Public Debut
Scribe, a company backed by pharmaceutical giants Eli Lilly and Sanofi, experienced a significant surge in its public market debut.
24 Jul, 17:35 — 24 Jul, 17:35
Sources
Showing 1 of 1 sources
